Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

Désirée Van Der Heijde, Atul Deodhar, Walter P. Maksymowych, Joachim Sieper, Filip Van Den Bosch, Tae Hwan Kim, Mitsumasa Kishimoto, Andrew J. Östör, Bernard Combe, Yunxia Sui, Yuanyuan Duan, Peter K. Wung, In Ho Song

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension'. Together they form a unique fingerprint.

Medicine & Life Sciences